| http://www.w3.org/ns/prov#value | - Committee recommendations are not binding on CDER, but the agency considers them carefully when deciding drug issues.CDER may especially want a committee's opinion about a new drug, a major indication for an already approved drug, or a special regulatory requirement being considered, such as a boxed warning in a drug's labeling.
|
